Arkansas-based NuShores Biosciences LLC Awarded $1.5 Million from NIH
Last year, NuShores Biosciences received a Fast Track Small Business Innovation Research (SBIR) award and has recently received additional funding of $1.5 million to build on the successes from the previous award. The new funding will support NuShores’ Years 2 and 3 Phase II studies. In the Phase I SBIR studies, NuShores demonstrated the feasibility of its NuCress™ bone filler scaffolds in craniofacial tissues. The NuCressTM scaffold has resulted in significantly earlier bone formation and significantly more graft being incorporated into the bone. The positive results spurred the additional funding.
Current grafting techniques for dental implants are associated with a variety of challenges, including difficulties with fixation and stabilization, insufficient bone regeneration, and high morbidity using autogenous block grafts. One way NuShores is using its research to address these issues is through investigating the advantage of NuCress™ technology to help dentists, periodontists, and oral surgeons with tooth salvage treatments at a reduced cost and with faster healing times than current technologies require.
“The Phase I SBIR results from our research collaborators indicate that our NuCressTM scaffold represents a robust technology that provides advanced bone formation with positive outcomes for complex craniomaxillofacial medical conditions.”
Read the full article from NuShores Biosciences here.